This inventor holds 5 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1988-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Takatsuki, JP (1988 - 1989)
- Kobe, JP (1994 - 1996)
Company Filing History:
Years Active: 1988-1996
Title: The Innovative Contributions of Yoshio Murakami
Introduction
Yoshio Murakami is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that utilize tricyclic compounds. With a total of 5 patents to his name, Murakami's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents is a "Suspendible composition and process for preparing the same." This invention involves a suspendible composition that includes a tricyclic compound, specifically FK 506, which can be used as an orally administrable agent or eye drops for treating various diseases. Another significant patent is for "Ointments containing FK-506 or derivatives thereof." This ointment comprises a tricyclic compound and is designed to treat various skin diseases, showcasing Murakami's focus on therapeutic applications.
Career Highlights
Yoshio Murakami is currently associated with Fujisawa Pharmaceutical Company, Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that utilize complex chemical compounds for medical purposes.
Collaborations
Murakami has collaborated with notable coworkers, including Sotoo Asakura and Toshiomi Nakate. These partnerships have likely contributed to the successful development of his patented inventions.
Conclusion
Yoshio Murakami's contributions to pharmaceutical innovations highlight the importance of research and development in creating effective medical treatments. His patents reflect a commitment to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
